Edition:
United States

Deciphera Pharmaceuticals Inc (DCPH.OQ)

DCPH.OQ on NASDAQ Stock Exchange Global Select Market

26.46USD
3:59pm EST
Change (% chg)

$-2.11 (-7.39%)
Prev Close
$28.57
Open
$28.57
Day's High
$28.57
Day's Low
$26.46
Volume
47,064
Avg. Vol
88,660
52-wk High
$45.61
52-wk Low
$18.56

Chart for

About

Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing drugs to improve the lives of cancer patients. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib. Its proprietary kinase switch control inhibitor platform, inhibit the activation of kinases. DCC-2618, an orally... (more)

Overall

Beta: --
Market Cap(Mil.): $1,075.98
Shares Outstanding(Mil.): 37.66
Dividend: --
Yield (%): --

Financials

  DCPH.OQ Industry Sector
P/E (TTM): -- 86.96 36.27
EPS (TTM): -2.60 -- --
ROI: -43.08 10.17 12.64
ROE: -123.84 10.42 13.67

Earnings vs. Estimates